TIDMGWP

RNS Number : 5384X

GW Pharmaceuticals PLC

13 January 2014

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or the underlying                GW Pharmaceuticals 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
--------------------------------------------------  ---------------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
-------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                      X 
-----------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
-----------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
-----------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights 
-----------------------------------------------------------------------------  ------- 
 Other (please 
  specify): 
-------------------  --------------------------------------------------------  ------- 
 3. Full name of person(s) subject                Prudential plc group of companies 
  to the 
  notification obligation: (iii) 
--------------------------------------------  ---------------------------------------- 
 4. Full name of shareholder(s)                         See attached schedule 
  (if different from 3.):(iv) 
--------------------------------------------  ---------------------------------------- 
 5. Date of the transaction and date                       09 January 2012 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
--------------------------------------------  ---------------------------------------- 
 6. Date on which issuer notified:                         10 January 2012 
--------------------------------------------  ---------------------------------------- 
 7. Threshold(s) that is/are crossed 
  or 
  reached: (vi, vii)                                          14% - 15% 
--------------------------------------------  ---------------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------------------------------ 
 Class/type     Situation previous                      Resulting situation after the triggering 
  of             to the triggering                       transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  --------------------------------------  ----------------------------------------------------------------------- 
                Number           Number                 Number         Number of voting           % of voting rights 
                 of               of                     of shares      rights                     (x) 
                 Shares           Voting 
                                  Rights 
-------------  ---------------  ---------------------  -------------  -------------------------  ----------------------------- 
                                                        Direct         Direct          Indirect   Direct           Indirect 
                                                                        (xi)            (xii) 
-------------  ---  ---  -----     ------  -----  ---  -------------  --------------  ---------  ---------------  ------------ 
 GB0030544687     18,861,389          26,241,389         20,661,389     20,661,389        0           11.60%            0 
-------------  ---------------  ---------------------  -------------  --------------  ---------  ---------------  ------------ 
 US36197T1034     7,380,000           7,380,000          7,380,000       7,380,000        0           4.15%             0 
-------------  ---------------  ---------------------  -------------  --------------  ---------  ---------------  ------------ 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------------ 
 Type of financial        Expiration        Exercise/                         Number of voting               % of voting 
  instrument               date (xiii)       Conversion Period                 rights that may                rights 
                                             (xiv)                             be 
                                                                               acquired if the 
                                                                               instrument is 
                                                                               exercised/ converted. 
-----------------------  ----------------  --------------------------------  -----------------------------  ------------------ 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------------ 
 Type of financial   Exercise       Expiration     Exercise/           Number of voting                % of voting rights 
  instrument          price          date (xvii)    Conversion          rights instrument               (xix, xx) 
                                                    period              refers to 
                                                    (xviii) 
------------------  -------------  -------------  ------------------  ------------------------------  ------------------------ 
                                                                                                       Nominal        Delta 
------------------  -------------  -------------  ------------------  ------------------------------  -------------  --------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                                             Percentage of voting rights 
------------------------------------------------------------------  ---------------------------------------------------------- 
 28,041,389                                                          15.75% 
------------------------------------------------------------------  ---------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
---------------------------------------------------------------------------------- 
 
   Prudential plc (parent Company) 
   M&G Group Limited (wholly owned subsidiary of Prudential plc) 
   M&G Limited (wholly owned subsidiary of M&G Group Limited) 
   M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) 
   M&G Securities Limited (wholly owned subsidiary of M&G Limited) 
 
 Proxy Voting: 
---------------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                     N/A 
-----------------------------------------------------  --------------------------- 
 11. Number of voting rights proxy holder will                     N/A 
  cease 
  to hold: 
-----------------------------------------------------  --------------------------- 
 12. Date on which proxy holder will cease to                      N/A 
  hold 
  voting rights: 
-----------------------------------------------------  --------------------------- 
 
 
  13. Additional information: 
-----------------------------------------  --------------------------------------- 
 14. Contact name:                          Poonam Stammers / Mark Thomas 
                                             M&G Investment Management Limited 
-----------------------------------------  --------------------------------------- 
 15. Contact telephone number:              020 3480 6135 / 020 7548 3266 
-----------------------------------------  ---------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAKFDFFELEFF

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.